11:54 O03 In vitro validation of the novel anti-CD19 and anti-CD38 UniCAR T cell therapy for refractory iTTP patients – Lisa Vermeersch

Belgium
  • Friday, 28 November

    Oral Presentations Basic Science

    Date: 28 Nov 2025Time: 11:30 - 12:30
Home › 11:54 O03 In vitro validation of the novel anti-CD19 and anti-CD38 UniCAR T cell therapy for refractory iTTP patients - Lisa Vermeersch
Website and marketing